4 Pharma Stocks to Buy, According to an Analyst. Novo Nordisk Isn't One.
Novo Nordisk(NVO) Barrons·2024-01-16 12:43The European pharmaceutical sector looks set for a good year on strong cash flows and attractive valuations, according to UBS analysts. They picked out four stocks that could particularly benefit but left out weight-loss drug pioneer and market darling Novo Nordisk, and struck a bearish note on AstraZeneca. ...